ROME–(BUSINESS WIRE)–#BloodMicrosampling–PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic partner in the Project-COMFORT consortium. This innovative public-private partnership, funded by Horizon Europe and supported by the Innovative Health Initiative Joint Undertaking (IHI JU), officially launched in November 2024, marking a transformative shift in blood … [Read more…]

VIENNA, Va.–(BUSINESS WIRE)–$CVM–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of a best-efforts public offering of 16,130,000 shares of its common stock (or pre-funded warrants (“Pre-Funded Warrants”) in lieu thereof). Each share of common stock (or Pre-Funded Warrant) is being sold at a public … [Read more…]

Global AIDS care nonprofit pays tribute to the 39th president of the United States as an unparalleled champion of human rights across the country and around the globe LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) mourns the death of United States President Jimmy Carter, a champion in the human rights movement. In February 2023, Carter, then … [Read more…]

Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile to intravenous Opdivo in the Phase 3 CheckMate-67T trial1,3 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CheckMate—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) granted … [Read more…]

Product combines fish-skin grafts and silicone for soft-tissue repair ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–#kerecis–Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of SurgiClose® Silicone, which combines a fish-skin graft and silicone backing for efficient treatment of … [Read more…]

MCKINNEY, Texas–(BUSINESS WIRE)–ScienceSoft has released its proprietary research exploring the potential of wearable devices in preventive healthcare for the geriatric population. Supported by data from statistical platforms, consumer surveys, and scientific research, the report predicts that within 5 to 10 years, one in two older adults will use wearable devices daily to forecast life-threatening risks. … [Read more…]

The float will Ride Down the Streets of Pasadena on New Year’s Day LOS ANGELES–(BUSINESS WIRE)–Forty-four honorees representing 9 states in the U.S. will be a part of the 2025 OneLegacy Donate Life Rose Parade® float on New Year’s Day. With ages ranging from 2 to 80 years old for floragraph honorees, and from 15 … [Read more…]

New indication based on results from a global Phase 3 trial demonstrating TEVIMBRA plus chemotherapy significantly improved overall survival for patients with advanced gastric cancers Second FDA approval for TEVIMBRA in 2024 SAN MATEO, Calif.–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders today announces the completion of enrollment of patients in the first cohort of the Audiogene Phase 1/2 gene therapy clinical trial. Recruitment … [Read more…]

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. (“GPCR Therapeutics”) on December 24, 2024, aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR Therapeutics’ ongoing drug development pipelines. Through … [Read more…]